scispace - formally typeset
Search or ask a question
Institution

Royal Devon and Exeter Hospital

HealthcareExeter, United Kingdom
About: Royal Devon and Exeter Hospital is a healthcare organization based out in Exeter, United Kingdom. It is known for research contribution in the topics: Population & Randomized controlled trial. The organization has 2282 authors who have published 2526 publications receiving 78866 citations. The organization is also known as: RD&E.


Papers
More filters
Journal ArticleDOI
TL;DR: This direct, randomised comparative analysis of two new treatment standards for hormone-naïve prostate cancer showed no evidence of a difference in overall or prostate cancer-specific survival, nor in other important outcomes such as symptomatic skeletal events.

195 citations

Journal ArticleDOI
TL;DR: In this article, clinical and experimental evidence is reviewed with respect to implant survival in relation to cement mantle thickness, and the so-called French paradox of excellent survival with thin cement mantles is discussed.
Abstract: In this chapter, clinical and experimental evidence is reviewed with respect to implant survival in relation to cement mantle thickness. The so-called French paradox of excellent survival with thin cement mantles is discussed. Cement mantles perceived as ≫thin≪ may in fact by thicker than expected.

194 citations

Journal ArticleDOI
Christopher A. Maxwell1, Javier Benitez, Laia Gómez-Baldó, Ana Osorio, Núria Bonifaci, Ricardo Fernandez-Ramires, Sylvain V. Costes2, Elisabet Guinó, Helen Chen1, G Evans1, Pooja Mohan1, Isabel Catala, Anna Petit, Helena Aguilar, Alberto Villanueva, Alvaro Aytes, Jordi Serra-Musach, Gad Rennert3, Flavio Lejbkowicz3, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Carla B. Ripamonti, Bernardo Bonanni4, Alessandra Viel, Anna Allavena5, Loris Bernard4, Paolo Radice, Eitan Friedman6, Bella Kaufman7, Yael Laitman7, Maya Dubrovsky7, Roni Milgrom7, Anna Jakubowska8, Cezary Cybulski8, Bohdan Górski8, Katarzyna Jaworska8, Katarzyna Durda8, Grzegorz Sukiennicki8, Jan Lubinski8, Yin Yao Shugart9, Susan M. Domchek10, Richard Letrero10, Barbara L. Weber11, Frans B. L. Hogervorst12, Matti A. Rookus12, J. Margriet Collée13, Peter Devilee14, Marjolijn J. L. Ligtenberg15, Rob B. van der Luijt16, Cora M. Aalfs17, Quinten Waisfisz18, Juul T. Wijnen14, Cornelis E. P. van Roozendaal19, Douglas F. Easton20, Susan Peock20, Margaret Cook20, Clare Oliver20, Debra Frost20, Patricia Harrington20, D. Gareth Evans21, Fiona Lalloo, Rosalind A. Eeles22, Louise Izatt23, Carol Chu24, Diana Eccles25, Fiona Douglas26, Carole Brewer27, Heli Nevanlinna28, Tuomas Heikkinen28, Fergus J. Couch29, Noralane M. Lindor29, Xianshu Wang29, Andrew K. Godwin30, Maria A. Caligo31, Grazia Lombardi31, Niklas Loman, Per Karlsson32, Hans Ehrencrona33, Anna von Wachenfeldt34, Rosa B. Barkardottir, Ute Hamann35, Muhammad Usman Rashid35, Adriana Lasa36, Trinidad Caldés37, Raquel Andrés38, Michael Schmitt39, Volker Assmann40, Kristen N. Stevens41, Kenneth Offit42, Joao Curado43, Hagen Tilgner43, Roderic Guigó43, Gemma Aiza, Joan Brunet, Joan Castellsague, Griselda Martrat, Ander Urruticoechea, Ignacio Blanco, Laima Tihomirova44, David E. Goldgar45, Saundra S. Buys45, Esther M. John46, Alexander Miron47, Melissa C. Southey48, Mary B. Daly49, Rita K. Schmutzler50, Barbara Wappenschmidt50, Alfons Meindl51, Norbert Arnold52, Helmut Deissler53, Raymonda Varon-Mateeva54, Christian Sutter55, Dieter Niederacher56, Evgeny Imyamitov, Olga M. Sinilnikova, Dominique Stoppa-Lyonne57, Sylvie Mazoyer58, Carole Verny-Pierre58, Laurent Castera57, Antoine De Pauw57, Yves-Jean Bignon, Nancy Uhrhammer, Jean-Philippe Peyrat, Philippe Vennin, Sandra Fert Ferrer, Marie-Agnès Collonge-Rame59, Isabelle Mortemousque, Amanda B. Spurdle60, Jonathan Beesley60, Xiaoqing Chen60, Sue Healey60, Mary Helen Barcellos-Hoff61, Marc Vidal47, Stephen B. Gruber41, Conxi Lázaro, Gabriel Capellá, Lesley McGuffog20, Katherine L. Nathanson20, Antonis C. Antoniou20, Georgia Chenevix-Trench60, Markus C. Fleisch56, Victor Moreno, Miguel Angel Pujana 
Family Research Institute1, Lawrence Berkeley National Laboratory2, Technion – Israel Institute of Technology3, European Institute of Oncology4, University of Turin5, Tel Aviv University6, Sheba Medical Center7, Pomeranian Medical University8, National Institutes of Health9, University of Pennsylvania10, Novartis11, Netherlands Cancer Institute12, Erasmus University Rotterdam13, Leiden University14, Radboud University Nijmegen15, Utrecht University16, University of Amsterdam17, VU University Amsterdam18, Maastricht University19, University of Cambridge20, Central Manchester University Hospitals NHS Foundation Trust21, The Royal Marsden NHS Foundation Trust22, Guy's and St Thomas' NHS Foundation Trust23, St James's University Hospital24, Princess Anne Hospital25, Newcastle upon Tyne Hospitals NHS Foundation Trust26, Royal Devon and Exeter Hospital27, University of Helsinki28, Mayo Clinic29, University of Kansas30, University of Pisa31, University of Gothenburg32, Uppsala University33, Karolinska Institutet34, German Cancer Research Center35, Memorial Hospital of South Bend36, Complutense University of Madrid37, University of Zaragoza38, University of Rostock39, University of Hamburg40, University of Michigan41, Memorial Sloan Kettering Cancer Center42, Pompeu Fabra University43, Latvian Biomedical Research and Study centre44, University of Utah45, Cancer Prevention Institute of California46, Harvard University47, University of Melbourne48, Fox Chase Cancer Center49, University of Cologne50, Technische Universität München51, University of Kiel52, University of Ulm53, Charité54, Heidelberg University55, University of Düsseldorf56, University of Paris57, University of Lyon58, University of Franche-Comté59, QIMR Berghofer Medical Research Institute60, New York University61
TL;DR: Cell biological analysis of the protein product suggests a function in regulating development of the mammary gland and genetic analysis identifies the HMMR gene as a modifier of the breast cancer risk associated with BRCA1 gene mutation.
Abstract: Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio ((w)HR) = 1.09 (95% CI 1.02-1.16), p(trend) = 0.017; and n = 3,965, (w)HR = 1.04 (95% CI 0.94-1.16), p(trend) = 0.43; respectively. Subsequently, studies of MCF10A apicobasal polarization revealed a central role for BRCA1 and RHAMM, together with AURKA and TPX2, in essential reorganization of microtubules. Mechanistically, reorganization is facilitated by BRCA1 and impaired by AURKA, which is regulated by negative feedback involving RHAMM and TPX2. Taken together, our data provide fundamental insight into apicobasal polarization through BRCA1 function, which may explain the expanded cell subsets and characteristic tumor type accompanying BRCA1 mutation, while also linking this process to sporadic breast cancer through perturbation of HMMR/RHAMM.

190 citations

Journal ArticleDOI
TL;DR: It is argued that action researchers and participants working in their own organizations should be clear about the extent to which they are engaged in a political activity, and that AR does not offer the same ethical guarantees concerning confidentiality and anonymity, informed consent, and protection from harm as other research methodologies.
Abstract: Aim. This paper contributes to an understanding of the political and ethical aspects of action research (AR). Background. Action research is growing in popularity in nursing and health care as a means of changing practice and generating new knowledge. As a methodology, AR relies on a close collaborative working relationship between researcher and participants, but this close relationship is also the source of political and ethical problems faced by researchers and participants. Content. We argue that action researchers and participants working in their own organizations should be clear about the extent to which they are engaged in a political activity, and that AR does not offer the same ethical guarantees concerning confidentiality and anonymity, informed consent, and protection from harm as other research methodologies (both quantitative and qualitative). This argument is illustrated by our experiences of participation in an AR study. Conclusion. We outline three areas where AR is implicitly political, and three areas where it is ethically problematic. We recommend that researchers and participants recognize, discuss and negotiate these problematic areas before starting their work.

189 citations

Journal ArticleDOI
04 Aug 2011-Blood
TL;DR: In elderly patients with newly diagnosed multiple myeloma (median age, 73 years), CTDa produced higher response rates than MP but was not associated with improved survival outcomes, which highlights the importance of cytogenetic profiling at diagnosis and effective management of adverse events.

187 citations


Authors

Showing all 2288 results

NameH-indexPapersCitations
Andrew T. Hattersley146768106949
Timothy M. Frayling133500100344
Gordon D.O. Lowe10556044327
Rod S Taylor10452439332
Sian Ellard9763636847
Zoltán Kutalik9032142901
Michael N. Weedon8720160701
Masud Husain8139825682
David Melzer8032833458
Jonathan Mill7830136343
A. John Camm7636849804
David Silver7422781103
Jason D. Warren7338420588
Nicholas J. Talbot7124029205
Andrew R. Wood7021436203
Network Information
Related Institutions (5)
Royal Hallamshire Hospital
8.4K papers, 314.4K citations

86% related

Southampton General Hospital
9.9K papers, 546.6K citations

85% related

St Thomas' Hospital
15.5K papers, 624.3K citations

84% related

Manchester Royal Infirmary
7.1K papers, 277.7K citations

84% related

Royal Free Hospital
15.7K papers, 651.9K citations

84% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20231
20225
2021153
2020142
2019160
2018152